Moneycontrol

You are Here : Drug pricing policy issue hurting sector's growth: Biocon

Friday, 12:19

Biotechnology major Biocon which today posted a strong first quarter earnings raised concerns about confusion in the India drug pricing policy which has impacted the growth of the pharma-biotech sector.
JUN 24, 2017
02:34 PM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On